FutureGen
Changping
About FutureGen
FutureGen is a biopharmaceutical company that develops innovative biologics. The company works in the fields of immunology and cancer, concentrating on the creation and commercialization of novel biologics. The STEP (Structure-based Targeted Evolution Platform) from FutureGen is a cutting-edge screening platform designed specifically for protein drug screening. It integrates several technologies to quickly screen and produce the best antibodies. FutureGen has experience in medication development, clinical research, CMC, and quality in the business world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $46.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2021)
- Website: futuregen.com.cn
- Phone: + 86-10-60709130
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Canonical: https://fsome.com/organization/futuregen-56704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.